Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity

被引:98
作者
Grover, GJ [1 ]
Atwal, KS [1 ]
Sleph, PG [1 ]
Wang, FL [1 ]
Monshizadegan, H [1 ]
Monticello, T [1 ]
Green, DW [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Metab & Cardiovasc Drug Discovery, Pennington, NJ 08534 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2004年 / 287卷 / 04期
关键词
ischemia; heart; reperfusion;
D O I
10.1152/ajpheart.01019.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mitochondrial F1F0-ATPase normally synthesizes ATP in the heart, but under ischemic conditions this enzyme paradoxically causes ATP hydrolysis. Nonselective inhibitors of this enzyme (aurovertin, oligomycin) inhibit ATP synthesis in normal tissue but also inhibit ATP hydrolysis in ischemic myocardium. We characterized the profile of aurovertin and oligomycin in ischemic and nonischemic rat myocardium and compared this with the profile of BMS-199264, which only inhibits F1F0-ATP hydrolase activity. In isolated rat hearts, aurovertin (1-10 muM) and oligomycin (10 muM), at concentrations inhibiting ATPase activity, reduced ATP concentration and contractile function in the nonischemic heart but significantly reduced the rate of ATP depletion during ischemia. They also inhibited recovery of reperfusion ATP and contractile function, consistent with nonselective F1F0-ATPase inhibitory activity, which suggests that upon reperfusion, the hydrolase activity switches back to ATP synthesis. BMS-199264 inhibits F1F0 hydrolase activity in submitochondrial particles with no effect on ATP synthase activity. BMS-199264 (1-10 muM) conserved ATP in rat hearts during ischemia while having no effect on preischemic contractile function or ATP concentration. Reperfusion ATP levels were replenished faster and necrosis was reduced by BMS-199264. ATP hydrolase activity ex vivo was selectively inhibited by BMS-199264. Therefore, excessive ATP hydrolysis by F1F0-ATPase contributes to the decline in cardiac energy reserve during ischemia and selective inhibition of ATP hydrolase activity can protect ischemic myocardium.
引用
收藏
页码:H1747 / H1755
页数:9
相关论文
共 32 条
[1]   Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents.: Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors [J].
Atwal, KS ;
Wan, P ;
Rogers, WL ;
Sleph, P ;
Monshizadegan, H ;
Ferrara, FN ;
Traeger, S ;
Green, DW ;
Grover, GJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) :1081-1084
[2]   Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity [J].
Bosetti, F ;
Yu, GY ;
Zucchi, R ;
Ronca-Testoni, S ;
Solaini, G .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2000, 215 (1-2) :31-37
[3]   REVERSIBLE MODULATION OF THE MITOCHONDRIAL ATP SYNTHASE WITH ENERGY DEMAND IN CULTURED RAT CARDIOMYOCYTES [J].
DAS, AM ;
HARRIS, DA .
FEBS LETTERS, 1989, 256 (1-2) :97-100
[4]  
GASINER F, 1993, ANAL BIOCHEM, V211, P173
[5]   The IF1 inhibitor protein of the mitochondrial F1F0-ATPase [J].
Green, DW ;
Grover, GJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2000, 1458 (2-3) :343-355
[6]   Preconditioning in rat hearts is independent of mitochondrial F1F0 ATPase inhibition [J].
Green, DW ;
Murray, HN ;
Sleph, PG ;
Wang, FL ;
Baird, AJ ;
Rogers, WL ;
Grover, GJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01) :H90-H97
[7]   Glyburide-reversible cardioprotective effects of BMS-180448: Functional and energetic considerations [J].
Grover, GJ ;
Sleph, PG ;
Dzwonczyk, S ;
Malone, HJ ;
Behling, RW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (01) :28-38
[8]  
Grover GJ, 2001, J PHARMACOL EXP THER, V297, P1184
[9]   ATP-sensitive potassium channels: A review of their cardioprotective pharmacology [J].
Grover, GJ ;
Garlid, KD .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (04) :677-695
[10]   CONTROL OF MITOCHONDRIAL ATP SYNTHESIS IN THE HEART [J].
HARRIS, DA ;
DAS, AM .
BIOCHEMICAL JOURNAL, 1991, 280 :561-573